Go Pro

HP (HPQ) Financials

HP logo
$32.69 +0.76 (+2.39%)
As of 02:08 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for HP

Annual Income Statements for HP

This table shows HP's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Net Income / (Loss) Attributable to Common Shareholders
4,554 2,496 2,526 5,327 3,152 2,815 6,541 3,132 3,263 2,775 2,529
Consolidated Net Income / (Loss)
4,554 2,496 2,526 5,327 3,152 2,815 6,541 3,132 3,263 2,775 2,529
Net Income / (Loss) Continuing Operations
3,718 2,666 2,526 5,327 3,152 2,815 6,541 3,132 3,263 2,775 2,529
Total Pre-Tax Income
3,532 3,761 3,276 3,013 2,523 3,211 7,568 4,324 2,937 3,279 2,668
Total Operating Income
3,920 3,549 3,368 3,831 3,877 3,442 5,359 4,559 3,456 3,818 3,174
Total Gross Profit
9,939 8,998 9,578 10,669 11,170 10,421 13,407 12,263 11,508 11,818 11,392
Total Revenue
51,463 48,238 52,056 58,472 58,756 56,638 63,460 62,910 53,718 53,559 55,295
Operating Revenue
51,463 48,238 52,056 58,472 58,756 56,638 63,460 62,910 53,718 53,559 55,295
Total Cost of Revenue
41,524 39,240 42,478 47,803 47,586 46,217 50,053 50,647 42,210 41,741 43,903
Operating Cost of Revenue
41,524 39,240 42,478 47,803 47,586 46,217 50,053 50,647 42,210 41,741 43,903
Total Operating Expenses
6,019 5,449 6,210 6,838 7,293 6,979 8,048 7,704 8,052 8,000 8,218
Selling, General & Admin Expense
4,719 3,833 4,532 5,099 5,368 4,901 5,727 5,264 5,357 5,658 5,821
Research & Development Expense
1,191 1,209 1,190 1,404 1,499 1,477 1,848 1,653 1,578 1,640 1,602
Amortization Expense
102 16 1.00 80 116 113 154 228 350 318 345
Restructuring Charge
64 212 487 255 310 488 319 559 767 384 450
Total Other Income / (Expense), net
-388 212 -92 -818 -1,354 -231 2,209 -235 -519 -539 -506
Other Income / (Expense), net
-388 212 -92 -818 -1,354 -231 2,209 -235 -519 -539 -506
Income Tax Expense
-186 1,095 750 -2,314 -629 396 1,027 1,192 -326 504 139
Basic Earnings per Share
$2.51 $1.44 $1.50 $3.30 $2.08 $1.99 $5.41 $3.02 $3.29 $2.83 $2.67
Weighted Average Basic Shares Outstanding
1.81B 1.73B 1.69B 1.62B 1.52B 1.41B 1.21B 1.04B 992M 979M 946M
Diluted Earnings per Share
$2.48 $1.43 $1.48 $3.26 $2.07 $1.98 $5.36 $2.98 $3.26 $2.81 $2.65
Weighted Average Diluted Shares Outstanding
1.84B 1.74B 1.70B 1.63B 1.52B 1.42B 1.22B 1.05B 1B 989M 953M
Weighted Average Basic & Diluted Shares Outstanding
1.81B 1.73B 1.68B 1.61B 1.45B 1.29B 1.08B 982.15M 990.90M 937.80M 917.98M
Cash Dividends to Common per Share
$0.67 $0.50 $0.53 $0.56 $0.64 $0.70 $0.78 $1.00 $1.05 $1.10 $1.16

Quarterly Income Statements for HP

This table shows HP's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders
622 607 640 906 565 406 763 795 545 450 661
Consolidated Net Income / (Loss)
622 607 640 906 565 406 763 795 545 450 661
Net Income / (Loss) Continuing Operations
622 607 640 906 565 406 763 795 545 450 661
Total Pre-Tax Income
793 797 827 862 704 506 624 834 671 493 798
Total Operating Income
935 952 940 991 845 654 716 959 759 612 892
Total Gross Profit
2,888 3,023 2,906 3,001 2,840 2,739 2,851 2,962 2,835 3,016 2,945
Total Revenue
13,185 12,800 13,519 14,055 13,504 13,220 13,932 14,639 14,438 14,408 15,677
Operating Revenue
13,185 12,800 13,519 14,055 13,504 13,220 13,932 14,639 14,438 14,408 15,677
Total Cost of Revenue
10,297 9,777 10,613 11,054 10,664 10,481 11,081 11,677 11,603 11,392 12,732
Operating Cost of Revenue
10,297 9,777 10,613 11,054 10,664 10,481 11,081 11,677 11,603 11,392 12,732
Total Operating Expenses
1,953 2,071 1,966 2,010 1,995 2,085 2,135 2,003 2,076 2,404 2,053
Selling, General & Admin Expense
1,383 1,462 1,404 1,409 1,459 1,480 1,452 1,430 1,504 1,514 1,537
Research & Development Expense
399 436 413 392 397 401 406 398 392 432 389
Amortization Expense
81 80 81 76 63 65 159 58 56 89 75
Restructuring Charge
90 93 68 133 76 139 118 117 124 369 52
Total Other Income / (Expense), net
-142 -155 -113 -129 -141 -148 -92 -125 -88 -119 -94
Other Income / (Expense), net
-142 -155 -113 -129 -141 -148 -92 -125 -88 -119 -94
Income Tax Expense
171 190 187 -44 139 100 -139 39 126 43 137
Basic Earnings per Share
$0.63 $0.62 $0.65 $0.93 $0.60 $0.43 $0.81 $0.83 $0.59 $0.49 $0.72
Weighted Average Basic Shares Outstanding
995M 984M 979M 979M 948M 950M 947M 946M 926M 922M 919M
Diluted Earnings per Share
$0.62 $0.61 $0.65 $0.93 $0.59 $0.42 $0.80 $0.84 $0.58 $0.49 $0.71
Weighted Average Diluted Shares Outstanding
1.00B 990M 990M 989M 957M 956M 954M 953M 932M 925M 927M
Weighted Average Basic & Diluted Shares Outstanding
980.73M 978.56M 963.72M 937.80M 942.70M 939.27M 934.70M 917.98M 914.55M 914.52M 901.79M

Annual Cash Flow Statements for HP

This table details how cash moves in and out of HP's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Net Change in Cash & Equivalents
2,300 -11,145 709 -1,831 -629 327 -565 -1,154 87 21 460
Net Cash From Operating Activities
7,026 3,252 3,677 4,528 4,654 4,316 6,409 4,463 3,571 3,749 3,697
Net Cash From Continuing Operating Activities
7,026 3,252 3,677 4,528 4,654 4,316 6,409 4,463 3,571 3,749 3,697
Net Income / (Loss) Continuing Operations
4,554 2,496 2,526 5,327 3,152 2,815 6,541 3,132 3,263 2,775 2,529
Consolidated Net Income / (Loss)
4,554 2,496 2,526 5,327 3,152 2,815 6,541 3,132 3,263 2,775 2,529
Depreciation Expense
4,061 332 354 528 744 789 785 780 850 830 916
Non-Cash Adjustments To Reconcile Net Income
3,152 350 720 719 826 1,137 873 881 845 550 912
Changes in Operating Assets and Liabilities, net
-4,741 74 77 -2,046 -68 -425 -1,790 -330 -1,387 -406 -660
Net Cash From Investing Activities
-5,534 48 -1,717 -716 -438 -1,016 -1,012 -3,549 -590 -646 -1,177
Net Cash From Continuing Investing Activities
-5,534 48 -1,717 -716 -438 -1,016 -1,012 -3,549 -590 -646 -1,177
Purchase of Property, Plant & Equipment
-3,603 -433 -402 -546 -671 -580 -582 -765 -593 -592 -897
Acquisitions
-2,644 -7.00 0.00 -1,036 -458 0.00 -854 -2,755 -7.00 -58 -116
Purchase of Investments
-259 -126 -1,400 -367 -80 -693 -28 -52 -11 -4.00 -40
Divestitures
246 475 - - - - - - 0.00 0.00 66
Sale and/or Maturity of Investments
302 133 231 847 771 417 304 9.00 21 8.00 74
Other Investing Activities, net
- 0.00 -215 214 0.00 -163 148 14 0.00 0.00 -264
Net Cash From Financing Activities
808 -14,445 -1,251 -5,643 -4,845 -2,973 -5,962 -2,068 -2,894 -3,082 -2,060
Net Cash From Continuing Financing Activities
808 -14,445 -1,251 -5,643 -4,845 -2,973 -5,962 -2,068 -2,894 -3,082 -2,060
Repayment of Debt
-15,867 -2,091 -87 -2,951 -1,536 -1,849 -845 -1,093 -1,710 -213 -1,387
Repurchase of Common Equity
-2,883 -1,161 -1,412 -2,557 -2,405 -3,107 -6,249 -4,297 -100 -2,100 -850
Payment of Dividends
-1,250 -858 -894 -899 -970 -997 -938 -1,037 -1,037 -1,075 -1,088
Issuance of Debt
20,832 4.00 1,094 712 127 3,108 2,121 4,175 255 380 1,385
Other Financing Activities, net
-24 -10,339 48 52 -61 -128 -51 184 -302 -74 -120
Cash Interest Paid
532 318 322 329 240 227 261 305 548 441 437
Cash Income Taxes Paid
1,012 587 438 951 89 464 1,548 749 398 649 535

Quarterly Cash Flow Statements for HP

This table details how cash moves in and out of HP's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Change in Cash & Equivalents
-815 100 361 375 -359 -164 144 839 -559 549 466
Net Cash From Operating Activities
121 581 1,424 1,623 374 38 1,661 1,624 383 926 1,735
Net Cash From Continuing Operating Activities
121 581 1,424 1,623 374 38 1,661 1,624 383 926 1,735
Net Income / (Loss) Continuing Operations
622 607 640 906 565 406 763 795 545 450 661
Consolidated Net Income / (Loss)
622 607 640 906 565 406 763 795 545 450 661
Depreciation Expense
205 209 208 208 197 205 306 208 214 264 244
Non-Cash Adjustments To Reconcile Net Income
158 153 89 150 299 249 218 146 314 444 227
Changes in Operating Assets and Liabilities, net
-864 -388 487 359 -687 -822 374 475 -690 -232 603
Net Cash From Investing Activities
-228 -49 -237 -132 -300 -833 20 -64 -269 -14 -182
Net Cash From Continuing Investing Activities
-228 -49 -237 -132 -300 -833 20 -64 -269 -14 -182
Purchase of Property, Plant & Equipment
-158 -119 -162 -153 -302 -183 -215 -197 -233 -170 -187
Purchase of Investments
0.00 - - -4.00 -3.00 -3.00 -17 -17 -5.00 -14 -2.00
Sale and/or Maturity of Investments
0.00 - - 8.00 5.00 9.00 55 5.00 19 6.00 7.00
Net Cash From Financing Activities
-708 -432 -826 -1,116 -433 631 -1,537 -721 -673 -363 -1,087
Net Cash From Continuing Financing Activities
-708 -432 -826 -1,116 -433 631 -1,537 -721 -673 -363 -1,087
Repayment of Debt
51 -153 -51 -60 -50 -52 -1,210 -75 -87 -81 -602
Repurchase of Common Equity
-500 -100 -600 -900 -100 -100 -150 -500 -325 -100 -300
Payment of Dividends
-275 -269 -268 -263 -273 -273 -272 -270 -277 -274 -274
Issuance of Debt
92 94 80 114 82 1,076 90 137 89 102 100
Other Financing Activities, net
-76 -4.00 13 -7.00 -92 -20 5.00 -13 -73 -10 -11

Annual Balance Sheets for HP

This table presents HP's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Total Assets
106,882 28,987 32,913 34,622 33,467 34,681 38,605 38,494 37,004 39,909 41,769
Total Current Assets
51,787 18,468 22,318 21,387 20,177 20,648 22,168 19,736 17,977 20,760 22,453
Cash & Equivalents
- 6,288 - 5,166 4,537 4,864 4,299 3,145 3,232 3,253 3,705
Accounts Receivable
4,825 4,114 4,414 5,113 6,031 5,381 5,536 4,546 4,237 5,117 5,692
Inventories, net
4,288 4,484 5,786 6,062 5,734 5,963 7,930 7,614 6,862 7,720 8,512
Other Current Assets
4,498 3,582 5,121 5,046 3,875 4,440 4,403 4,431 3,646 4,670 4,544
Plant, Property, & Equipment, net
1,492 1,736 1,878 2,198 2,794 2,627 2,546 2,774 2,827 2,914 3,049
Total Noncurrent Assets
7,272 8,783 8,717 11,037 10,496 11,406 13,891 15,984 16,200 16,235 16,267
Goodwill
5,680 5,622 5,622 5,968 6,372 6,380 6,803 8,541 8,591 8,627 8,706
Other Noncurrent Operating Assets
1,592 3,161 3,095 5,069 4,124 5,026 7,088 7,443 7,609 7,608 7,561
Total Liabilities & Shareholders' Equity
106,882 28,987 32,913 34,622 33,467 34,681 38,605 38,494 37,004 39,909 41,769
Total Liabilities
26,286 32,876 28,680 35,261 34,660 36,909 40,249 41,519 38,073 41,232 42,115
Total Current Liabilities
42,191 18,808 22,412 25,131 25,293 26,220 29,061 26,189 24,488 28,687 29,258
Short-Term Debt
2,194 78 1,072 1,463 357 674 1,106 218 230 1,406 845
Accounts Payable
10,194 11,103 13,279 14,816 14,793 14,704 16,075 15,303 14,046 16,903 18,051
Other Current Liabilities
6,241 5,718 6,953 8,852 10,143 10,842 11,880 10,668 10,212 10,378 10,362
Total Noncurrent Liabilities
7,414 14,068 7,162 10,130 9,367 10,689 11,188 15,330 13,585 12,545 12,857
Long-Term Debt
- 6,735 - 4,524 4,780 5,543 6,386 10,796 9,254 8,263 8,821
Other Noncurrent Operating Liabilities
7,414 7,333 7,162 5,606 4,587 5,146 4,802 4,534 4,331 4,282 4,036
Total Equity & Noncontrolling Interests
27,768 -3,889 -3,408 -639 -1,193 -2,228 -1,644 -3,025 -1,069 -1,323 -346
Total Preferred & Common Equity
27,768 -3,889 -3,408 -639 -1,193 -2,228 -1,644 -3,025 -1,069 -1,323 -346
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
27,768 -3,889 -3,408 -639 -1,193 -2,228 -1,644 -3,025 -1,069 -1,323 -346
Common Stock
1,981 1,047 396 679 850 976 1,071 1,182 1,515 1,787 2,138
Retained Earnings
32,089 -3,498 -2,386 -473 -818 -1,961 -2,470 -4,492 -2,361 -2,676 -2,027
Accumulated Other Comprehensive Income / (Loss)
-6,302 -1,438 -1,418 -845 -1,225 -1,243 -245 285 -223 -434 -457

Quarterly Balance Sheets for HP

This table presents HP's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 1/31/2026 4/30/2026 7/31/2026
Total Assets
37,004 35,846 37,433 38,059 39,909 38,930 38,799 39,854 41,535 42,936 45,701
Total Current Assets
17,977 16,858 18,593 19,315 20,760 19,834 19,458 20,574 22,226 23,984 26,746
Cash & Equivalents
3,232 2,417 2,517 2,878 3,253 2,894 2,730 2,874 3,154 3,703 4,169
Accounts Receivable
4,237 3,804 4,319 4,659 5,117 4,188 4,336 5,123 5,332 6,125 7,168
Inventories, net
6,862 6,928 7,512 7,790 7,720 8,443 8,175 8,356 8,737 9,203 10,322
Other Current Assets
3,646 3,709 4,245 3,988 4,670 4,309 4,217 4,221 5,003 4,953 5,087
Plant, Property, & Equipment, net
2,827 2,807 2,794 2,831 2,914 2,900 2,951 2,993 3,053 3,079 3,110
Total Noncurrent Assets
16,200 16,181 16,046 15,913 16,235 16,196 16,390 16,287 16,256 15,873 15,845
Goodwill
8,591 8,610 8,590 8,606 8,627 8,599 8,713 8,714 8,724 8,730 8,726
Other Noncurrent Operating Assets
7,609 7,571 7,456 7,307 7,608 7,597 7,677 7,573 7,532 7,143 7,119
Total Liabilities & Shareholders' Equity
37,004 35,846 37,433 38,059 39,909 38,930 38,799 39,854 41,535 42,936 45,701
Total Liabilities
38,073 37,486 38,349 39,451 41,232 40,002 40,075 40,755 42,301 43,080 45,793
Total Current Liabilities
24,488 23,857 24,839 27,043 28,687 27,434 26,556 27,864 29,290 30,206 33,963
Short-Term Debt
230 359 265 1,396 1,406 1,418 1,446 820 861 810 1,292
Accounts Payable
14,046 13,255 14,362 15,447 16,903 16,483 15,195 16,985 18,220 19,173 21,383
Other Current Liabilities
10,212 10,243 10,212 10,200 10,378 9,533 9,915 10,059 10,209 10,223 11,288
Total Noncurrent Liabilities
13,585 13,629 13,510 12,408 12,545 12,568 13,519 12,891 13,011 12,874 11,830
Long-Term Debt
9,254 9,301 9,327 8,229 8,263 8,273 9,291 8,782 8,838 8,856 7,868
Other Noncurrent Operating Liabilities
4,331 4,328 4,183 4,179 4,282 4,295 4,228 4,109 4,173 4,018 3,962
Total Equity & Noncontrolling Interests
-1,069 -1,640 -916 -1,392 -1,323 -1,072 -1,276 -901 -766 -144 -92
Total Preferred & Common Equity
-1,069 -1,640 -916 -1,392 -1,323 -1,072 -1,276 -901 -766 -144 -92
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-1,069 -1,640 -916 -1,392 -1,323 -1,072 -1,276 -901 -766 -144 -92
Common Stock
1,515 1,589 1,673 1,752 1,787 1,883 2,008 2,100 2,216 2,317 2,373
Retained Earnings
-2,361 -2,771 -2,257 -2,729 -2,676 -2,751 -2,441 -2,360 -2,328 -1,960 -2,117
Accumulated Other Comprehensive Income / (Loss)
-223 -458 -332 -415 -434 -204 -843 -641 -654 -501 -348

Annual Metrics And Ratios for HP

This table displays calculated financial ratios and metrics derived from HP's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-9.16% -6.27% 7.91% 12.33% 0.49% -3.60% 12.04% -0.87% -14.61% -0.30% 3.24%
EBITDA Growth
-7.37% -46.10% -11.31% -2.45% -7.74% 22.44% 108.83% -38.90% -25.80% 8.50% -12.78%
EBIT Growth
-8.57% 6.48% -12.90% -8.03% -16.26% 27.27% 135.69% -42.86% -32.08% 11.64% -18.63%
NOPAT Growth
28.09% -39.03% 3.23% 160.82% -28.49% -37.70% 53.50% -28.71% 16.27% -15.85% -6.89%
Net Income Growth
-9.16% -45.19% 1.20% 110.89% -40.83% -10.69% 132.36% -52.12% 4.18% -14.96% -8.86%
EPS Growth
-9.16% -42.34% 3.50% 120.27% -36.50% -4.35% 170.71% -44.40% 9.40% -13.80% -5.69%
Operating Cash Flow Growth
-43.03% -53.71% 13.07% 23.14% 2.78% -7.26% 48.49% -30.36% -19.99% 4.98% -1.39%
Free Cash Flow Firm Growth
378.05% -90.44% -77.78% 429.68% 14.68% -41.27% -33.09% -99.67% 48,402.40% -5.13% -25.13%
Invested Capital Growth
-104.56% -95.92% 49.70% 110.76% -425.82% -47.55% 277.03% 212.72% 7.00% -1.74% 10.25%
Revenue Q/Q Growth
93.05% 41.32% 2.79% 2.52% 0.07% -0.26% 2.24% -2.89% -1.75% 0.45% 1.07%
EBITDA Q/Q Growth
25.92% -13.03% -4.07% 6.24% -12.11% 6.81% 52.01% -36.66% 5.81% 0.15% -0.78%
EBIT Q/Q Growth
85.80% 9.01% -4.71% 5.57% -16.95% 8.96% 60.54% -40.66% 7.50% 0.31% -1.04%
NOPAT Q/Q Growth
158.56% -35.77% 14.00% 19.17% -11.10% 1.59% 7.24% -25.20% 45.44% -3.27% -4.17%
Net Income Q/Q Growth
-0.15% -24.98% 7.12% 17.44% -25.22% 9.79% 61.79% -67.08% 440.96% -2.39% -4.20%
EPS Q/Q Growth
-0.15% 123.25% 5.71% 15.19% -23.90% 11.24% 67.50% -46.69% 41.13% -1.40% -3.28%
Operating Cash Flow Q/Q Growth
6.75% -42.72% -1.08% 6.79% -7.55% 42.44% 17.92% -17.46% 2.03% -8.58% 0.03%
Free Cash Flow Firm Q/Q Growth
4,189.84% -90.90% -18.86% -24.18% -0.77% 38.27% -47.18% -99.15% 1,497.92% -10.27% -6.78%
Invested Capital Q/Q Growth
-104.22% -195.61% 0.00% 123.39% 40.22% -114.46% 675.84% 47.01% -9.32% -4.89% -3.64%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
19.31% 18.65% 18.40% 18.25% 19.01% 18.40% 21.13% 19.49% 21.42% 22.07% 20.60%
EBITDA Margin
14.75% 8.49% 6.97% 6.06% 5.56% 7.06% 13.16% 8.11% 7.05% 7.67% 6.48%
Operating Margin
7.62% 7.36% 6.47% 6.55% 6.60% 6.08% 8.44% 7.25% 6.43% 7.13% 5.74%
EBIT Margin
6.86% 7.80% 6.29% 5.15% 4.29% 5.67% 11.93% 6.87% 5.47% 6.12% 4.83%
Profit (Net Income) Margin
8.85% 5.17% 4.85% 9.11% 5.36% 4.97% 10.31% 4.98% 6.07% 5.18% 4.57%
Tax Burden Percent
128.94% 66.37% 77.11% 176.80% 124.93% 87.67% 86.43% 72.43% 111.10% 84.63% 94.79%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
-5.27% 29.11% 22.89% -76.80% -24.93% 12.33% 13.57% 27.57% -11.10% 15.37% 5.21%
Return on Invested Capital (ROIC)
22.94% 0.00% 0.00% 0.00% 0.00% 0.00% 1,374.41% 103.31% 76.59% 62.89% 56.19%
ROIC Less NNEP Spread (ROIC-NNEP)
18.32% 0.00% 0.00% 0.00% 0.00% 0.00% 1,458.41% 100.23% 68.42% 55.69% 48.44%
Return on Net Nonoperating Assets (RNNOA)
-6.23% 0.00% 0.00% 0.00% 0.00% 0.00% -1,712.27% -237.47% -235.99% -294.91% -359.25%
Return on Equity (ROE)
16.71% 20.91% -69.23% -263.26% -344.10% -164.57% -337.86% -134.16% -159.40% -232.02% -303.06%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 2,691.88% 0.00% 0.00% 142.53% 0.23% 69.82% 64.64% 46.44%
Operating Return on Assets (OROA)
3.36% 5.54% 10.58% 8.92% 7.41% 9.42% 20.65% 11.22% 7.78% 8.53% 6.53%
Return on Assets (ROA)
4.34% 3.67% 8.16% 15.78% 9.26% 8.26% 17.85% 8.12% 8.64% 7.22% 6.19%
Return on Common Equity (ROCE)
16.71% 20.91% -69.23% -263.26% -344.10% -164.57% -337.86% -134.16% -159.40% -232.02% -303.06%
Return on Equity Simple (ROE_SIMPLE)
16.40% -64.18% -74.12% -833.65% -264.21% -126.35% -397.87% -103.54% -305.24% -209.75% 0.00%
Net Operating Profit after Tax (NOPAT)
4,126 2,516 2,597 6,773 4,844 3,018 4,632 3,302 3,840 3,231 3,009
NOPAT Margin
8.02% 5.22% 4.99% 11.58% 8.24% 5.33% 7.30% 5.25% 7.15% 6.03% 5.44%
Net Nonoperating Expense Percent (NNEP)
4.62% -0.14% 6.33% 114.01% 238.08% 20.74% -84.00% 3.08% 8.17% 7.20% 7.75%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 41.33% 45.63% 38.72% 32.28%
Cost of Revenue to Revenue
80.69% 81.35% 81.60% 81.75% 80.99% 81.60% 78.87% 80.51% 78.58% 77.93% 79.40%
SG&A Expenses to Revenue
9.17% 7.95% 8.71% 8.72% 9.14% 8.65% 9.02% 8.37% 9.97% 10.56% 10.53%
R&D to Revenue
2.31% 2.51% 2.29% 2.40% 2.55% 2.61% 2.91% 2.63% 2.94% 3.06% 2.90%
Operating Expenses to Revenue
11.70% 11.30% 11.93% 11.69% 12.41% 12.32% 12.68% 12.25% 14.99% 14.94% 14.86%
Earnings before Interest and Taxes (EBIT)
3,532 3,761 3,276 3,013 2,523 3,211 7,568 4,324 2,937 3,279 2,668
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7,593 4,093 3,630 3,541 3,267 4,000 8,353 5,104 3,787 4,109 3,584
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
1.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.71 0.40 0.56 0.54 0.38 0.39 0.50 0.41 0.46 0.63 0.47
Price to Earnings (P/E)
8.04 7.80 11.63 5.95 6.99 7.79 4.88 8.20 7.64 12.23 10.23
Dividend Yield
3.30% 4.36% 3.04% 2.78% 4.31% 4.42% 2.80% 3.92% 4.16% 3.13% 4.18%
Earnings Yield
12.44% 12.82% 8.60% 16.82% 14.30% 12.84% 20.49% 12.19% 13.08% 8.17% 9.78%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 178.57 0.00 0.00 22.67 6.93 6.02 7.93 5.67
Enterprise Value to Revenue (EV/Rev)
0.75 0.41 0.58 0.56 0.39 0.41 0.55 0.53 0.58 0.75 0.58
Enterprise Value to EBITDA (EV/EBITDA)
5.11 4.89 8.39 9.18 6.93 5.82 4.20 6.58 8.24 9.82 8.88
Enterprise Value to EBIT (EV/EBIT)
10.99 5.32 9.29 10.79 8.97 7.25 4.64 7.76 10.62 12.31 11.93
Enterprise Value to NOPAT (EV/NOPAT)
9.40 7.95 11.72 4.80 4.68 7.71 7.58 10.16 8.12 12.49 10.58
Enterprise Value to Operating Cash Flow (EV/OCF)
5.52 6.15 8.28 7.18 4.87 5.39 5.48 7.52 8.74 10.77 8.61
Enterprise Value to Free Cash Flow (EV/FCFF)
0.89 4.80 32.92 6.63 4.03 7.05 15.91 4,650.35 8.91 12.15 12.80
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.08 -1.75 -0.31 -9.37 -4.31 -2.79 -4.56 -3.64 -8.87 -7.31 -27.94
Long-Term Debt to Equity
0.00 -1.73 0.00 -7.08 -4.01 -2.49 -3.88 -3.57 -8.66 -6.25 -25.49
Financial Leverage
-0.34 -1.21 -0.31 -0.63 -0.78 -0.57 -1.17 -2.37 -3.45 -5.30 -7.42
Leverage Ratio
3.85 5.69 -8.48 -16.69 -37.17 -19.92 -18.93 -16.51 -18.44 -32.15 -48.94
Compound Leverage Factor
3.85 5.69 -8.48 -16.69 -37.17 -19.92 -18.93 -16.51 -18.44 -32.15 -48.94
Debt to Total Capital
7.32% 233.00% -45.89% 111.95% 130.25% 155.85% 128.11% 137.86% 112.70% 115.85% 103.71%
Short-Term Debt to Total Capital
7.32% 2.67% -45.89% 27.36% 9.05% 16.90% 18.91% 2.73% 2.73% 16.85% 9.07%
Long-Term Debt to Total Capital
0.00% 230.34% 0.00% 84.59% 121.20% 138.96% 109.20% 135.14% 109.97% 99.01% 94.65%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
92.68% -133.00% 145.89% -11.95% -30.25% -55.85% -28.11% -37.86% -12.70% -15.85% -3.71%
Debt to EBITDA
0.29 1.66 0.30 1.69 1.57 1.55 0.90 2.16 2.50 2.35 2.70
Net Debt to EBITDA
0.29 0.13 0.30 0.23 0.18 0.34 0.38 1.54 1.65 1.56 1.66
Long-Term Debt to EBITDA
0.00 1.65 0.00 1.28 1.46 1.39 0.76 2.12 2.44 2.01 2.46
Debt to NOPAT
0.53 2.71 0.41 0.88 1.06 2.06 1.62 3.34 2.47 2.99 3.21
Net Debt to NOPAT
0.53 0.21 0.41 0.12 0.12 0.45 0.69 2.38 1.63 1.99 1.98
Long-Term Debt to NOPAT
0.00 2.68 0.00 0.67 0.99 1.84 1.38 3.27 2.41 2.56 2.93
Altman Z-Score
1.95 2.26 2.42 2.37 2.17 2.02 2.46 2.01 1.81 1.77 1.64
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.23 0.98 1.00 0.85 0.80 0.79 0.76 0.75 0.73 0.72 0.77
Quick Ratio
0.11 0.55 0.20 0.41 0.42 0.39 0.34 0.29 0.31 0.29 0.32
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
43,538 4,163 925 4,899 5,619 3,300 2,208 7.22 3,501 3,321 2,487
Operating Cash Flow to CapEx
221.01% 761.59% 1,104.20% 1,210.70% 693.59% 748.01% 1,101.20% 583.40% 602.19% 633.28% 412.15%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.49 0.71 1.68 1.73 1.73 1.66 1.73 1.63 1.42 1.39 1.35
Accounts Receivable Turnover
5.52 10.79 12.21 12.28 10.54 9.93 11.63 12.48 12.23 11.45 10.23
Inventory Turnover
7.76 8.95 8.27 8.07 8.07 7.90 7.21 6.52 5.83 5.73 5.41
Fixed Asset Turnover
8.02 29.89 28.81 28.69 23.54 20.90 24.54 23.65 19.18 18.66 18.55
Accounts Payable Turnover
3.18 3.69 3.48 3.40 3.21 3.13 3.25 3.23 2.88 2.70 2.51
Days Sales Outstanding (DSO)
66.16 33.82 29.90 29.74 34.61 36.77 31.40 29.25 29.84 31.87 35.67
Days Inventory Outstanding (DIO)
47.04 40.80 44.12 45.23 45.24 46.19 50.66 56.01 62.59 63.76 67.47
Days Payable Outstanding (DPO)
114.70 99.05 104.75 107.26 113.56 116.48 112.22 113.07 126.89 135.32 145.30
Cash Conversion Cycle (CCC)
-1.50 -24.43 -30.73 -32.29 -33.70 -33.52 -30.17 -27.81 -34.47 -39.69 -42.15
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-1,717 -3,364 -1,692 182 -593 -875 1,549 4,844 5,183 5,093 5,615
Invested Capital Turnover
2.86 -18.99 -20.59 -77.45 -285.92 -77.16 188.31 19.68 10.71 10.42 10.33
Increase / (Decrease) in Invested Capital
-39,412 -1,647 1,672 1,874 -775 -282 2,424 3,295 339 -90 522
Enterprise Value (EV)
38,800 19,995 30,444 32,499 22,644 23,273 35,122 33,563 31,196 40,364 31,824
Market Capitalization
36,606 19,470 29,372 31,678 22,044 21,920 31,929 25,694 24,944 33,948 25,863
Book Value per Share
$15.44 ($2.27) ($2.02) ($0.40) ($0.81) ($1.62) ($1.43) ($3.01) ($1.08) ($1.37) ($0.37)
Tangible Book Value per Share
$12.28 ($5.56) ($5.35) ($4.18) ($5.10) ($6.27) ($7.33) ($11.50) ($9.77) ($10.32) ($9.68)
Total Capital
29,962 2,924 -2,336 5,348 3,944 3,989 5,848 7,989 8,415 8,346 9,320
Total Debt
2,194 6,813 1,072 5,987 5,137 6,217 7,492 11,014 9,484 9,669 9,666
Total Long-Term Debt
0.00 6,735 0.00 4,524 4,780 5,543 6,386 10,796 9,254 8,263 8,821
Net Debt
2,194 525 1,072 821 600 1,353 3,193 7,869 6,252 6,416 5,961
Capital Expenditures (CapEx)
3,179 427 333 374 671 577 582 765 593 592 897
Debt-free, Cash-free Net Working Capital (DFCFNWC)
11,790 -6,550 978 -7,447 -9,296 -9,762 -10,086 -9,380 -9,513 -9,774 -9,665
Debt-free Net Working Capital (DFNWC)
11,790 -262 978 -2,281 -4,759 -4,898 -5,787 -6,235 -6,281 -6,521 -5,960
Net Working Capital (NWC)
9,596 -340 -94 -3,744 -5,116 -5,572 -6,893 -6,453 -6,511 -7,927 -6,805
Net Nonoperating Expense (NNE)
-428 20 71 1,446 1,692 203 -1,909 170 577 456 480
Net Nonoperating Obligations (NNO)
-29,485 525 1,716 821 600 1,353 3,193 7,869 6,252 6,416 5,961
Total Depreciation and Amortization (D&A)
4,061 332 354 528 744 789 785 780 850 830 916
Debt-free, Cash-free Net Working Capital to Revenue
22.91% -13.58% 1.88% -12.74% -15.82% -17.24% -15.89% -14.91% -17.71% -18.25% -17.48%
Debt-free Net Working Capital to Revenue
22.91% -0.54% 1.88% -3.90% -8.10% -8.65% -9.12% -9.91% -11.69% -12.18% -10.78%
Net Working Capital to Revenue
18.65% -0.70% -0.18% -6.40% -8.71% -9.84% -10.86% -10.26% -12.12% -14.80% -12.31%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.51 $1.44 $1.50 $3.30 $2.08 $2.01 $5.38 $0.00 $3.29 $2.83 $2.67
Adjusted Weighted Average Basic Shares Outstanding
1.81B 1.73B 1.69B 1.62B 1.52B 1.41B 1.21B 0.00 992M 979M 946M
Adjusted Diluted Earnings per Share
$2.48 $1.43 $1.48 $3.26 $2.07 $2.00 $5.33 $0.00 $3.26 $2.81 $2.65
Adjusted Weighted Average Diluted Shares Outstanding
1.84B 1.74B 1.70B 1.63B 1.52B 1.42B 1.22B 0.00 1B 989M 953M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $2.08 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.79B 1.71B 165.23M 1.55B 1.45B 1.29B 1.08B 0.00 990.90M 937.80M 917.98M
Normalized Net Operating Profit after Tax (NOPAT)
2,749 2,793 2,972 2,860 2,931 3,445 4,907 3,707 2,956 3,556 3,435
Normalized NOPAT Margin
5.34% 5.79% 5.71% 4.89% 4.99% 6.08% 7.73% 5.89% 5.50% 6.64% 6.21%
Pre Tax Income Margin
6.86% 7.80% 6.29% 5.15% 4.29% 5.67% 11.93% 6.87% 5.47% 6.12% 4.83%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
27.45% 34.38% 35.39% 16.88% 30.77% 35.42% 14.34% 33.11% 31.78% 38.74% 43.02%
Augmented Payout Ratio
90.76% 80.89% 91.29% 64.88% 107.07% 145.79% 109.88% 170.31% 34.85% 114.41% 76.63%

Quarterly Metrics And Ratios for HP

This table displays calculated financial ratios and metrics derived from HP's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
DEI Shares Outstanding
- - - - - - - - - 914,550,199.00 914,522,690.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 914,550,199.00 914,522,690.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.49 0.72
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.44% -0.83% 2.45% 1.72% 2.42% 3.28% 3.06% 4.16% 6.92% 8.99% 12.53%
EBITDA Growth
29.44% 25.91% -10.23% 0.56% -9.72% -29.32% -10.14% -2.62% -1.78% 6.47% 12.04%
EBIT Growth
41.10% 35.78% -11.65% 1.17% -11.22% -36.51% -24.55% -3.25% -4.69% -2.57% 27.88%
NOPAT Growth
18.28% -45.94% -6.63% -10.15% -7.53% -27.63% 20.35% -12.23% -9.10% 6.45% -15.61%
Net Income Growth
32.62% -42.41% -16.45% -6.98% -9.16% -33.11% 19.22% -12.25% -3.54% 10.84% -13.37%
EPS Growth
31.91% -42.45% -14.47% -4.12% -4.84% -31.15% 23.08% -9.68% -1.69% 16.67% -11.25%
Operating Cash Flow Growth
856.25% -8.65% 45.90% -17.82% 209.09% -93.46% 16.64% 0.06% 2.41% 2,336.84% 4.46%
Free Cash Flow Firm Growth
111.81% 133.55% 166.29% 37.97% 42.47% -106.37% -62.93% -65.34% 1.14% 3,212.49% 313.11%
Invested Capital Growth
6.52% -0.28% -6.32% -1.74% 2.18% 9.29% 8.81% 10.25% 0.94% -13.55% -15.93%
Revenue Q/Q Growth
-4.57% -2.92% 5.62% 3.96% -3.92% -2.10% 5.39% 5.07% -1.37% -0.21% 8.81%
EBITDA Q/Q Growth
-6.20% 0.80% 2.88% 3.38% -15.79% -21.09% 30.80% 12.04% -15.07% -14.46% 37.65%
EBIT Q/Q Growth
-6.92% 0.50% 3.76% 4.23% -18.33% -28.13% 23.32% 33.65% -19.54% -26.53% 61.87%
NOPAT Q/Q Growth
-36.73% -1.14% 0.33% 43.18% -34.89% -22.62% 66.84% 4.42% -32.56% -9.38% 32.27%
Net Income Q/Q Growth
-36.14% -2.41% 5.44% 41.56% -37.64% -28.14% 87.93% 4.19% -31.45% -17.43% 46.89%
EPS Q/Q Growth
-36.08% -1.61% 6.56% 43.08% -36.56% -28.81% 90.48% 5.00% -30.95% -15.52% 44.90%
Operating Cash Flow Q/Q Growth
-93.87% 380.17% 145.09% 13.97% -76.96% -89.84% 4,271.05% -2.23% -76.42% 141.78% 87.37%
Free Cash Flow Firm Q/Q Growth
-52.40% 90.08% 46.68% 3.96% -50.85% -108.50% 953.97% -2.81% 43.43% 161.46% 13.34%
Invested Capital Q/Q Growth
8.10% 9.92% -13.05% -4.89% 12.41% 17.57% -13.43% -3.64% 2.92% 0.69% -15.81%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.90% 23.62% 21.50% 21.35% 21.03% 20.72% 20.46% 20.23% 19.64% 20.93% 18.79%
EBITDA Margin
7.57% 7.86% 7.66% 7.61% 6.67% 5.38% 6.68% 7.12% 6.13% 5.25% 6.65%
Operating Margin
7.09% 7.44% 6.95% 7.05% 6.26% 4.95% 5.14% 6.55% 5.26% 4.25% 5.69%
EBIT Margin
6.01% 6.23% 6.12% 6.13% 5.21% 3.83% 4.48% 5.70% 4.65% 3.42% 5.09%
Profit (Net Income) Margin
4.72% 4.74% 4.73% 6.45% 4.18% 3.07% 5.48% 5.43% 3.77% 3.12% 4.22%
Tax Burden Percent
78.44% 76.16% 77.39% 105.10% 80.26% 80.24% 122.28% 95.32% 81.22% 91.28% 82.83%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
21.56% 23.84% 22.61% -5.10% 19.74% 19.76% -22.28% 4.68% 18.78% 8.72% 17.17%
Return on Invested Capital (ROIC)
54.38% 48.68% 51.83% 77.25% 47.77% 33.44% 61.49% 64.49% 41.74% 35.48% 51.99%
ROIC Less NNEP Spread (ROIC-NNEP)
53.01% 47.17% 50.64% 75.11% 46.16% 31.87% 59.82% 62.57% 40.67% 33.92% 50.66%
Return on Net Nonoperating Assets (RNNOA)
-160.25% -218.32% -204.80% -397.78% -238.96% -219.26% -351.56% -463.99% -295.21% -333.72% -597.91%
Return on Equity (ROE)
-105.86% -169.65% -152.97% -320.53% -191.19% -185.82% -290.06% -399.50% -253.47% -298.24% -545.91%
Cash Return on Invested Capital (CROIC)
66.11% 55.18% 66.87% 64.64% 53.93% 37.33% 47.71% 46.44% 50.18% 61.80% 69.97%
Operating Return on Assets (OROA)
8.87% 8.94% 8.73% 8.54% 7.51% 5.45% 6.29% 7.71% 6.50% 4.81% 7.04%
Return on Assets (ROA)
6.96% 6.81% 6.76% 8.98% 6.03% 4.37% 7.69% 7.35% 5.28% 4.39% 5.83%
Return on Common Equity (ROCE)
-105.86% -169.65% -152.97% -320.53% -191.19% -185.82% -290.06% -399.50% -253.47% -298.24% -545.91%
Return on Equity Simple (ROE_SIMPLE)
-208.29% -324.13% -204.24% 0.00% -253.54% -197.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
733 725 727 1,042 678 525 875 914 616 559 739
NOPAT Margin
5.56% 5.66% 5.38% 7.41% 5.02% 3.97% 6.28% 6.24% 4.27% 3.88% 4.71%
Net Nonoperating Expense Percent (NNEP)
1.37% 1.50% 1.19% 2.14% 1.61% 1.57% 1.67% 1.93% 1.07% 1.56% 1.33%
Return On Investment Capital (ROIC_SIMPLE)
9.14% - - 12.48% 7.87% 5.55% 10.06% 9.81% 6.90% 5.87% 8.15%
Cost of Revenue to Revenue
78.10% 76.38% 78.50% 78.65% 78.97% 79.28% 79.54% 79.77% 80.36% 79.07% 81.21%
SG&A Expenses to Revenue
10.49% 11.42% 10.39% 10.02% 10.80% 11.20% 10.42% 9.77% 10.42% 10.51% 9.80%
R&D to Revenue
3.03% 3.41% 3.06% 2.79% 2.94% 3.03% 2.91% 2.72% 2.72% 3.00% 2.48%
Operating Expenses to Revenue
14.81% 16.18% 14.54% 14.30% 14.77% 15.77% 15.32% 13.68% 14.38% 16.69% 13.10%
Earnings before Interest and Taxes (EBIT)
793 797 827 862 704 506 624 834 671 493 798
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
998 1,006 1,035 1,070 901 711 930 1,042 885 757 1,042
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.52 0.52 0.66 0.63 0.57 0.44 0.43 0.47 0.32 0.33 0.42
Price to Earnings (P/E)
8.03 9.21 12.42 12.23 11.21 9.58 8.82 10.23 7.11 7.47 10.18
Dividend Yield
3.83% 3.86% 3.02% 3.13% 3.43% 4.42% 4.61% 4.18% 6.01% 5.65% 4.36%
Earnings Yield
12.45% 10.86% 8.05% 8.17% 8.92% 10.44% 11.33% 9.78% 14.06% 13.38% 9.83%
Enterprise Value to Invested Capital (EV/IC)
6.19 5.59 7.85 7.93 6.51 4.77 5.15 5.67 4.22 4.30 6.11
Enterprise Value to Revenue (EV/Rev)
0.65 0.65 0.79 0.75 0.69 0.59 0.55 0.58 0.43 0.44 0.51
Enterprise Value to EBITDA (EV/EBITDA)
8.64 8.15 10.25 9.82 9.29 8.64 8.31 8.88 6.84 6.93 8.03
Enterprise Value to EBIT (EV/EBIT)
10.95 10.19 12.87 12.31 11.69 11.08 11.14 11.93 9.26 9.55 10.70
Enterprise Value to NOPAT (EV/NOPAT)
8.82 10.16 12.59 12.49 11.74 10.78 9.56 10.58 8.30 8.44 10.60
Enterprise Value to Operating Cash Flow (EV/OCF)
9.36 9.42 10.26 10.77 9.31 9.28 8.12 8.61 6.58 5.45 6.41
Enterprise Value to Free Cash Flow (EV/FCFF)
9.66 10.11 11.36 12.15 12.20 13.35 11.26 12.80 8.45 6.46 7.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-5.89 -10.47 -6.91 -7.31 -9.04 -8.41 -10.66 -27.94 -12.66 -67.13 -99.57
Long-Term Debt to Equity
-5.67 -10.18 -5.91 -6.25 -7.72 -7.28 -9.75 -25.49 -11.54 -61.50 -85.52
Financial Leverage
-3.02 -4.63 -4.04 -5.30 -5.18 -6.88 -5.88 -7.42 -7.26 -9.84 -11.80
Leverage Ratio
-13.41 -21.71 -20.54 -32.15 -27.57 -34.78 -33.98 -48.94 -43.78 -57.56 -86.16
Compound Leverage Factor
-13.41 -21.71 -20.54 -32.15 -27.57 -34.78 -33.98 -48.94 -43.78 -57.56 -86.16
Debt to Total Capital
120.45% 110.56% 116.91% 115.85% 112.44% 113.49% 110.36% 103.71% 108.57% 101.51% 101.01%
Short-Term Debt to Total Capital
4.48% 3.05% 16.96% 16.85% 16.45% 15.28% 9.42% 9.07% 9.64% 8.51% 14.25%
Long-Term Debt to Total Capital
115.97% 107.50% 99.95% 99.01% 95.99% 98.20% 100.93% 94.65% 98.94% 93.01% 86.77%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-20.45% -10.56% -16.91% -15.85% -12.44% -13.49% -10.36% -3.71% -8.57% -1.51% -1.01%
Debt to EBITDA
2.41 2.27 2.35 2.35 2.42 2.89 2.66 2.70 2.72 2.67 2.46
Net Debt to EBITDA
1.80 1.68 1.64 1.56 1.69 2.15 1.86 1.66 1.83 1.65 1.34
Long-Term Debt to EBITDA
2.32 2.21 2.01 2.01 2.06 2.50 2.43 2.46 2.48 2.45 2.11
Debt to NOPAT
2.46 2.83 2.88 2.99 3.05 3.61 3.06 3.21 3.30 3.26 3.24
Net Debt to NOPAT
1.84 2.09 2.02 1.99 2.14 2.69 2.14 1.98 2.23 2.01 1.77
Long-Term Debt to NOPAT
2.36 2.75 2.46 2.56 2.60 3.12 2.80 2.93 3.01 2.99 2.79
Altman Z-Score
1.65 1.63 1.67 1.58 1.57 1.50 1.47 1.49 1.38 1.40 1.42
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.71 0.75 0.71 0.72 0.72 0.73 0.74 0.77 0.76 0.79 0.79
Quick Ratio
0.26 0.28 0.28 0.29 0.26 0.27 0.29 0.32 0.29 0.33 0.33
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
390 742 1,088 1,132 556 -47 403 392 562 1,471 1,667
Operating Cash Flow to CapEx
76.58% 488.24% 879.01% 1,060.78% 123.84% 20.77% 772.56% 824.37% 164.38% 544.71% 927.81%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.48 1.44 1.43 1.39 1.44 1.42 1.40 1.35 1.40 1.41 1.38
Accounts Receivable Turnover
13.09 12.54 11.82 11.45 13.48 12.55 11.19 10.23 11.81 10.98 9.63
Inventory Turnover
5.82 5.60 5.54 5.73 5.48 5.46 5.36 5.41 5.22 5.27 5.08
Fixed Asset Turnover
19.06 19.05 19.00 18.66 18.88 18.90 18.79 18.55 18.89 19.04 19.39
Accounts Payable Turnover
3.10 2.98 2.81 2.70 2.83 2.90 2.67 2.51 2.58 2.66 2.47
Days Sales Outstanding (DSO)
27.89 29.12 30.89 31.87 27.07 29.09 32.63 35.67 30.90 33.25 37.91
Days Inventory Outstanding (DIO)
62.77 65.14 65.88 63.76 66.62 66.87 68.08 67.47 69.92 69.32 71.91
Days Payable Outstanding (DPO)
117.72 122.37 129.98 135.32 128.89 126.00 136.76 145.30 141.24 137.09 147.71
Cash Conversion Cycle (CCC)
-27.06 -28.12 -33.21 -39.69 -35.20 -30.04 -36.04 -42.15 -40.42 -34.52 -37.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,603 6,159 5,355 5,093 5,725 6,731 5,827 5,615 5,779 5,819 4,899
Invested Capital Turnover
9.78 8.59 9.63 10.42 9.51 8.42 9.79 10.33 9.78 9.15 11.03
Increase / (Decrease) in Invested Capital
343 -17 -361 -90 122 572 472 522 54 -912 -928
Enterprise Value (EV)
34,690 34,415 42,063 40,364 37,275 32,112 30,022 31,824 24,391 25,041 29,930
Market Capitalization
27,447 27,340 35,316 33,948 30,478 24,105 23,294 25,863 17,846 19,078 24,939
Book Value per Share
($1.65) ($0.93) ($1.42) ($1.37) ($1.14) ($1.35) ($0.96) ($0.37) ($0.83) ($0.16) ($0.10)
Tangible Book Value per Share
($10.30) ($9.69) ($10.22) ($10.32) ($10.31) ($10.60) ($10.24) ($9.68) ($10.34) ($9.70) ($9.64)
Total Capital
8,020 8,676 8,233 8,346 8,619 9,461 8,701 9,320 8,933 9,522 9,068
Total Debt
9,660 9,592 9,625 9,669 9,691 10,737 9,602 9,666 9,699 9,666 9,160
Total Long-Term Debt
9,301 9,327 8,229 8,263 8,273 9,291 8,782 8,821 8,838 8,856 7,868
Net Debt
7,243 7,075 6,747 6,416 6,797 8,007 6,728 5,961 6,545 5,963 4,991
Capital Expenditures (CapEx)
158 119 162 153 302 183 215 197 233 170 187
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-9,057 -8,498 -9,210 -9,774 -9,076 -8,382 -9,344 -9,665 -9,357 -9,115 -10,094
Debt-free Net Working Capital (DFNWC)
-6,640 -5,981 -6,332 -6,521 -6,182 -5,652 -6,470 -5,960 -6,203 -5,412 -5,925
Net Working Capital (NWC)
-6,999 -6,246 -7,728 -7,927 -7,600 -7,098 -7,290 -6,805 -7,064 -6,222 -7,217
Net Nonoperating Expense (NNE)
111 118 87 136 113 119 112 119 71 109 78
Net Nonoperating Obligations (NNO)
7,243 7,075 6,747 6,416 6,797 8,007 6,728 5,961 6,545 5,963 4,991
Total Depreciation and Amortization (D&A)
205 209 208 208 197 205 306 208 214 264 244
Debt-free, Cash-free Net Working Capital to Revenue
-17.05% -16.03% -17.27% -18.25% -16.85% -15.44% -17.08% -17.48% -16.64% -15.88% -17.06%
Debt-free Net Working Capital to Revenue
-12.50% -11.29% -11.88% -12.18% -11.47% -10.41% -11.83% -10.78% -11.03% -9.43% -10.01%
Net Working Capital to Revenue
-13.18% -11.79% -14.49% -14.80% -14.11% -13.07% -13.32% -12.31% -12.56% -10.84% -12.20%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.63 $0.62 $0.65 $0.93 $0.60 $0.43 $0.81 $0.83 $0.59 $0.49 $0.72
Adjusted Weighted Average Basic Shares Outstanding
995M 984M 979M 979M 948M 950M 947M 946M 926M 922M 919M
Adjusted Diluted Earnings per Share
$0.62 $0.61 $0.65 $0.93 $0.59 $0.42 $0.80 $0.84 $0.58 $0.49 $0.71
Adjusted Weighted Average Diluted Shares Outstanding
1.00B 990M 990M 989M 957M 956M 954M 953M 932M 925M 927M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
980.73M 978.56M 963.72M 937.80M 942.70M 939.27M 934.70M 917.98M 914.55M 914.52M 901.79M
Normalized Net Operating Profit after Tax (NOPAT)
804 796 780 787 739 636 584 1,026 717 895 782
Normalized NOPAT Margin
6.10% 6.22% 5.77% 5.60% 5.47% 4.81% 4.19% 7.01% 4.97% 6.21% 4.99%
Pre Tax Income Margin
6.01% 6.23% 6.12% 6.13% 5.21% 3.83% 4.48% 5.70% 4.65% 3.42% 5.09%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.83% 35.80% 37.71% 38.74% 39.48% 42.79% 40.95% 43.02% 43.52% 42.81% 44.68%
Augmented Payout Ratio
45.46% 56.01% 79.92% 114.41% 102.02% 110.33% 88.30% 76.63% 86.37% 84.92% 94.66%

Financials Breakdown Chart

Key Financial Trends

HPQ’s latest results show improving revenue and cash generation, but profitability and balance-sheet quality remain mixed. In Q3 fiscal 2026, revenue rose to $15.7 billion, up approximately 12.5% from the restated $13.9 billion reported in Q3 fiscal 2025. Operating income increased 24.6% year over year to $892 million, helped by lower restructuring charges and higher sales. However, net income declined 13.4% to $661 million, while diluted EPS fell from $0.80 to $0.71.

Cash flow has become a significant strength. Q3 operating cash flow reached $1.7 billion, compared with $1.66 billion a year earlier. For the first three quarters of fiscal 2026, operating cash flow totaled approximately $3.0 billion, versus $2.1 billion during the comparable period of fiscal 2025. HPQ also ended Q3 with $4.2 billion in cash, up from $2.9 billion at the end of Q3 fiscal 2025.

The balance sheet has improved in some areas, although working-capital requirements have expanded. Total debt declined to approximately $9.2 billion from $9.6 billion year over year, and negative shareholders’ equity narrowed substantially to $92 million from $901 million. Nevertheless, inventories increased to $10.3 billion and accounts receivable rose to $7.2 billion, while current liabilities reached $34.0 billion. This leaves current assets below current liabilities, highlighting continued liquidity risk despite the larger cash balance.

  • Revenue momentum improved: Q3 fiscal 2026 revenue of $15.7 billion was the highest among the provided quarterly periods and increased approximately 12.5% year over year.
  • Operating performance strengthened year over year: Operating income rose to $892 million from $716 million in Q3 fiscal 2025, and the operating margin improved to roughly 5.7% from 5.1%.
  • Operating cash flow remains robust: Q3 operating cash flow was $1.735 billion, and fiscal 2026 year-to-date operating cash flow was approximately $3.0 billion, well above the comparable fiscal 2025 period.
  • Cash reserves increased: Cash and equivalents rose to $4.169 billion by July 31, 2026, up approximately 45% from Q3 fiscal 2025.
  • Debt declined modestly: Short-term and long-term debt totaled about $9.16 billion in Q3 fiscal 2026, below the approximately $9.60 billion reported a year earlier.
  • Shareholder returns continue: HPQ repurchased $300 million of common stock and paid $274 million in dividends during Q3, supported by strong operating cash generation.
  • Capital spending remains controlled: Q3 capital expenditures were $187 million, below quarterly operating cash flow, although continued investment will be necessary to support product development and competitiveness.
  • Restructuring activity is still recurring: Restructuring charges fell to $52 million in Q3 from $369 million in Q2, but the repeated charges across recent quarters indicate that restructuring benefits and costs may continue to affect reported earnings.
  • Net income and EPS weakened: Q3 net income fell to $661 million from $763 million year over year, while diluted EPS declined to $0.71 from $0.80.
  • Margins remain under pressure: Q3 gross margin was approximately 18.8%, below 20.5% in the restated year-ago quarter. Higher revenue has not yet translated into consistent bottom-line growth.
  • Working-capital and liquidity risks remain elevated: Inventory and receivables have increased sharply, while current liabilities of $34.0 billion exceeded current assets of $26.7 billion. Shareholders’ equity also remained slightly negative at quarter-end.
09/04/26 12:07 PM ETAI Generated. May Contain Errors.

HP Financials - Frequently Asked Questions

According to the most recent income statement we have on file, HP's financial year ends in October. Their financial year 2025 ended on October 31, 2025.

In the past 10 years, HP's net income has ranged from $2.50 billion in 2016 to $6.54 billion in 2021, and is currently $2.53 billion as of their latest financial filing in 2025. See where experts think HP is headed by visiting HP's forecast page.

HP's total operating income in 2025 was $3.17 billion, based on the following breakdown:
  • Total Gross Profit: $11.39 billion
  • Total Operating Expenses: $8.22 billion

Over the last 10 years, HP's total revenue changed from $51.46 billion in 2015 to $55.30 billion in 2025, a change of 7.4%.

HP's total liabilities were at $42.12 billion at the end of 2025, a 2.1% increase from 2024, and a 60.2% increase since 2015.

In the past 10 years, HP's cash and equivalents has ranged from $0.00 in 2015 to $6.29 billion in 2016, and is currently $3.71 billion as of their latest financial filing in 2025.

Over the last 10 years, HP's book value per share changed from 15.44 in 2015 to -0.37 in 2025, a change of -102.4%.



Financial statements for NYSE:HPQ last updated on 8/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners